![Aleksandra Rizo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aleksandra Rizo
Directeur/Bestuurslid bij
SYNDAX PHARMACEUTICALS, INC.
Vermogen: 546 500 $ op 30-06-2026
Profiel
Aleksandra Rizo is currently President, Chief Executive Officer & Director at Vividion Therapeutics, Inc. since 2023 and Independent Director at Syndax Pharmaceuticals, Inc. starting in 2024.
Former positions include Chief Medical Officer & Executive Vice President at Geron Corp.
from 2019 to 2022, Executive Director-Strategy & Clinical Leader at Celgene Corp.
from 2018 to 2019, and Senior Director & Team Leader Compound Development at Janssen Research & Development LLC from 2014 to 2018.
Education includes doctorates from the University of Groningen, the University of Tokyo, and Saints Cyril & Methodius University of Skopje.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-03-2026 | 25.000 ( 0,03% ) | 546 500 $ | 30-06-2026 |
Actieve functies van Aleksandra Rizo
| Bedrijven | Functie | Begin |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 14-05-2024 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Algemeen Directeur | 24-01-2023 |
Eerdere bekende functies van Aleksandra Rizo
| Bedrijven | Functie | Einde |
|---|---|---|
| GERON CORPORATION | Hoofd Techniek/Wetenschap/O&O | 08-07-2022 |
| CELGENE | Corporate Officer/Principal | 01-01-2019 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | 01-03-2018 |
Opleiding van Aleksandra Rizo
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Saints Cyril & Methodius University of Skopje
 Saints Cyril & Methodius University of Skopje Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
